Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01489514 · ClinicalTrials.gov registry record
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 22
- Enrollment target
NCT01489514 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 22 participants.
The verdict
NCT01489514 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This is a proof of concept study to determine the safety and allergenicity of hypoallergenic peanut product extract as compared to standard peanut extract in an adult population with known peanut allergy. This will be assessed by epicutaneous skin prick testing. The hypothesis is that subjects with previously diagnosed peanut allergy will have less epicutaneous reactions to the hypoallergenic peanut product extract.
Interventions
- OTHER Epicutaneous skin prick testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01489514
The ClinicalTrials.gov registry entry for NCT01489514 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epicutaneous skin prick testing is the first listed.
NCT01489514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01489514 about?
NCT01489514 is a clinical study titled "Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects". This is a proof of concept study to determine the safety and allergenicity of hypoallergenic peanut product extract as compared to standard peanut extract in an adult population with known peanut allergy. This will be assessed by epicutaneous skin prick testing. The hypothesis is that subjects with ...
What is the current status of trial NCT01489514?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-12. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01489514?
The interventions under investigation include: Epicutaneous skin prick testing (OTHER).
Who is sponsoring clinical trial NCT01489514?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.